George Bickerstaff is an renowned American businessman and philanthropist. He co-founded M.M. Dillon & Company and has held executive roles in healthcare and technology industries for over 35 years.
He currently holds the positions of Chairman and Vice-Chairman of both the International Vaccine Institute and International Centre for Missing and Exploited Children, respectively. Furthermore, he serves as director of numerous public and private companies as well as foundations.
Early Life and Education
Early childhood education is vital for a child’s development. It’s during these formative years that kids learn many essential life skills, such as social interaction, self-worth, and moral values.
Parents and educators strive to create learning-friendly environments for children, knowing that the early years are critical as this is when their brains develop fastest. Doing so helps them absorb more information, making school preparation much smoother.
Contrary to popular belief, children learn a tremendous amount during their preschool years. According to studies, “preschool-aged children experience profound biological brain development and reach 90% of adult brain volume by age 6.”
George Bickerstaff is a renowned professional in the National Basketball Association (NBA). He currently serves as senior advisor to the Cleveland Cavaliers.
His career has seen him hold a variety of positions, such as head coach and general manager for several teams.
Despite his success, he remains humble and generous. This quality can be seen in his relationships with his teammates and the NBA.
George is an acclaimed philanthropist and serves on the boards of directors for CareDx Inc. and Cardax, Inc. He holds degrees in engineering and business administration from Rutgers University as well as Executive Education credentials from Harvard Business School.
Achievements and Honors
George Bickerstaff holds a Bachelor of Science in engineering and an Bachelor of Arts in business administration from Rutgers University, as well as executive education credentials from Harvard Business School.
He is currently the co-founder and managing director of M.M. Dillon & Co, an investment bank focused on healthcare and technology. Prior to that he held senior positions with Novartis Pharma AG in Switzerland as well as IMS Health.
He has served on the boards of more than twenty global companies and foundations, often chairing key committees. Recently he served on Ariad Pharmaceuticals, Axovant Sciences, Cardax, CareDx, Innoviva and Inovio Pharmaceuticals’ public boards.
He has earned the distinction of 2016 Mitchell Scholar from York High School and serves as Student Listener at York Middle School. Furthermore, he is actively involved in his community by volunteering weekly at York Public Library throughout his high school career.
George Bickerstaff was a self-taught artist who lived an eclectic life before settling in California in 1922. He created beautiful oil paintings of mountain and desert scenes, featuring eucalyptus trees and rolling hills of wildflowers native to California.
His paintings often sold well, and he had the knack of marketing himself. In addition to seascapes and still lives, he painted western and Indian scenes as well.
He was an active member of the Church of Jesus Christ of Latter-day Saints, with so many callings within the church that it would be impossible to list them all. But his greatest passion lay in spreading the gospel.
On October 31, 2009 in Whitianga, New Zealand he suffered a heart attack while waiting for an All Blacks game to start. Survived by his wife and 17 children plus one grandchild, he will be greatly missed.
George Bickerstaff is the co-founder of M.M. Dillon & Co, an investment bank that works with healthcare and technology companies. Previously, he held senior executive roles in corporate finance including chief financial officer at Novartis Pharma AG. Furthermore, George serves on the boards of several public companies such as Innoviva, CareDx and Cardax.
On November 23, 2022, George Bickerstaff owned 60,101 shares of CareDx stock worth $4.34 million dollars and 15,000 units of Innoviva Inc stock worth $658,707; these investments have been made over the past 5 years and can be tracked on Form 4. To stay informed on George’s trading activity in CareDx shares, sign up for our free daily insider email alerts!